Literature DB >> 20569726

Chronic kidney disease and prevalent atrial fibrillation: the Chronic Renal Insufficiency Cohort (CRIC).

Elsayed Z Soliman1, Ronald J Prineas, Alan S Go, Dawei Xie, James P Lash, Mahboob Rahman, Akinlolu Ojo, Val L Teal, Nancy G Jensvold, Nancy L Robinson, Daniel L Dries, Lydia Bazzano, Emile R Mohler, Jackson T Wright, Harold I Feldman.   

Abstract

BACKGROUND: The epidemiology of atrial fibrillation (AF) has been mainly investigated in patients with end-stage renal disease, with limited data on less advanced chronic kidney disease (CKD) stages.
METHODS: A total of 3,267 adult participants (50% non-Hispanic blacks, 46% women) with CKD from the Chronic Renal Insufficiency Cohort were included in this study. None of the study participants had been on dialysis. Those with self-identified race/ethnicity other than non-Hispanic black or white (n = 323) or those without electrocardiographic data (n = 22) were excluded. Atrial fibrillation was ascertained by a 12-lead electrocardiogram and self-report. Age-, sex-, and race/ethnicity-specific prevalence rates of AF were estimated and compared between subgroups. Cross-sectional associations and correlates with prevalent AF were examined using unadjusted and multivariable-adjusted logistic regression analysis.
RESULTS: The mean estimated glomerular filtration rate was 43.6 (+/-13.0) mL/(min 1.73 m(2)). Atrial fibrillation was present in 18% of the study population and in >25% of those > or =70 years old. In multivariable-adjusted models, 1-SD increase in age (11 years) (odds ratio 1.27, CI 95% 1.13-1.43, P < .0001), male [corrected] sex (0.80, 0.65-0.98, P = .0303), smoking (former vs never) (1.34, 1.08-1.66, P = .0081), history of heart failure (3.28, 2.47-4.36, P < .001), and history of cardiovascular disease (1.94, 1.56-2.43, P < .0001) were significantly associated with AF. Race/ethnicity, hypertension, diabetes, body mass index, physical activity, education, high-sensitivity C-reactive protein, total cholesterol, and alcohol intake were not significantly associated with AF. An estimated glomerular filtration rate <45 mL/(min 1.73 m(2)) was associated with AF in an unadjusted model (1.35, 1.13-1.62, P = .0010), but not after multivariable adjustment (1.12, 0.92-1.35, P = .2710).
CONCLUSIONS: Nearly 1 in 5 participants in Chronic Renal Insufficiency Cohort, a national study of CKD, had evidence of AF at study entry, a prevalence similar to that reported among patients with end-stage renal disease and 2 to 3 times of that reported in the general population. Risk factors for AF in this CKD population do not mirror those reported in the general population. Copyright 2010 Mosby, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20569726      PMCID: PMC2891979          DOI: 10.1016/j.ahj.2010.03.027

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  50 in total

Review 1.  Atrial fibrillation in dialysis patients.

Authors:  H Zebe
Journal:  Nephrol Dial Transplant       Date:  2000-06       Impact factor: 5.992

2.  Compendium of physical activities: an update of activity codes and MET intensities.

Authors:  B E Ainsworth; W L Haskell; M C Whitt; M L Irwin; A M Swartz; S J Strath; W L O'Brien; D R Bassett; K H Schmitz; P O Emplaincourt; D R Jacobs; A S Leon
Journal:  Med Sci Sports Exerc       Date:  2000-09       Impact factor: 5.411

3.  Clinical characteristics associated to atrial fibrillation in chronic hemodialysis patients.

Authors:  F Fabbian; C Catalano; D Lambertini; G Tarroni; V Bordin; R Squerzanti; P Gilli; D Di Landro; R Cavagna
Journal:  Clin Nephrol       Date:  2000-09       Impact factor: 0.975

4.  Influence of atrial fibrillation on the morbido-mortality of patients on hemodialysis.

Authors:  E Vázquez; C Sánchez-Perales; F Borrego; M J Garcia-Cortés; C Lozano; M Guzmán; J M Gil; M J Borrego; V Pérez
Journal:  Am Heart J       Date:  2000-12       Impact factor: 4.749

5.  Prospective evaluation of a method for estimating ascending aortic pressure from the radial artery pressure waveform.

Authors:  A L Pauca; M F O'Rourke; N D Kon
Journal:  Hypertension       Date:  2001-10       Impact factor: 10.190

6.  Cardiovascular disease in patients with chronic kidney disease: getting to the heart of the matter.

Authors:  A Levin; O Djurdjev; B Barrett; E Burgess; E Carlisle; J Ethier; K Jindal; D Mendelssohn; S Tobe; J Singer; C Thompson
Journal:  Am J Kidney Dis       Date:  2001-12       Impact factor: 8.860

7.  Symptomatic atrial arrhythmias in hemodialysis patients.

Authors:  N Ansari; T Manis; D A Feinfeld
Journal:  Ren Fail       Date:  2001-01       Impact factor: 2.606

Review 8.  Stroke prevention in atrial fibrillation.

Authors:  R G Hart
Journal:  Curr Cardiol Rep       Date:  2000-01       Impact factor: 2.931

9.  Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the AnTicoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study.

Authors:  A S Go; E M Hylek; K A Phillips; Y Chang; L E Henault; J V Selby; D E Singer
Journal:  JAMA       Date:  2001-05-09       Impact factor: 56.272

10.  Atrial fibrillation at baseline and during follow-up in ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial).

Authors:  L Julian Haywood; Charles E Ford; Richard S Crow; Barry R Davis; Barry M Massie; Paula T Einhorn; Angela Williard
Journal:  J Am Coll Cardiol       Date:  2009-11-24       Impact factor: 24.094

View more
  118 in total

Review 1.  How Dangerous Is Hyperkalemia?

Authors:  John R Montford; Stuart Linas
Journal:  J Am Soc Nephrol       Date:  2017-08-04       Impact factor: 10.121

Review 2.  Balancing ischaemia and bleeding risks with novel oral anticoagulants.

Authors:  Usman Baber; Ioannis Mastoris; Roxana Mehran
Journal:  Nat Rev Cardiol       Date:  2014-11-04       Impact factor: 32.419

3.  Association of Fibroblast Growth Factor 23 With Atrial Fibrillation in Chronic Kidney Disease, From the Chronic Renal Insufficiency Cohort Study.

Authors:  Rupal Mehta; Xuan Cai; Jungwha Lee; Julia J Scialla; Nisha Bansal; James H Sondheimer; Jing Chen; L Lee Hamm; Ana C Ricardo; Sankar D Navaneethan; Rajat Deo; Mahboob Rahman; Harold I Feldman; Alan S Go; Tamara Isakova; Myles Wolf
Journal:  JAMA Cardiol       Date:  2016-08-01       Impact factor: 14.676

4.  Indication for Dialysis Initiation and Mortality in Patients With Chronic Kidney Failure: A Retrospective Cohort Study.

Authors:  Matthew B Rivara; Chang Huei Chen; Anupama Nair; Denise Cobb; Jonathan Himmelfarb; Rajnish Mehrotra
Journal:  Am J Kidney Dis       Date:  2017-01       Impact factor: 8.860

5.  The relationship between serum indoxyl sulfate and the renal function after catheter ablation of atrial fibrillation in patients with mild renal dysfunction.

Authors:  Hideki Koike; Toshisuke Morita; Junko Tatebe; Ippei Watanabe; Makiko Koike; Shintaro Yao; Masaya Shinohara; Hitomi Yuzawa; Takeya Suzuki; Tadashi Fujino; Takanori Ikeda
Journal:  Heart Vessels       Date:  2018-11-08       Impact factor: 2.037

6.  Early cerebrovascular events after transcatheter aortic valve replacement: patient- and procedure-specific predictors.

Authors:  Dale Murdoch; Jonathon P Fanning
Journal:  J Thorac Dis       Date:  2017-03       Impact factor: 2.895

7.  Chronic kidney disease: Safe anticoagulation for patients with CKD--are we there yet?

Authors:  Elsayed Z Soliman
Journal:  Nat Rev Nephrol       Date:  2012-11-13       Impact factor: 28.314

8.  Incident Atrial Fibrillation and the Risk of Stroke in Adults with Chronic Kidney Disease: The Stockholm CREAtinine Measurements (SCREAM) Project.

Authors:  Juan Jesus Carrero; Marco Trevisan; Manish M Sood; Peter Bárány; Hong Xu; Marie Evans; Leif Friberg; Karolina Szummer
Journal:  Clin J Am Soc Nephrol       Date:  2018-07-20       Impact factor: 8.237

9.  Trends in the incidence of atrial fibrillation in older patients initiating dialysis in the United States.

Authors:  Benjamin A Goldstein; Cristina M Arce; Mark A Hlatky; Mintu Turakhia; Soko Setoguchi; Wolfgang C Winkelmayer
Journal:  Circulation       Date:  2012-10-02       Impact factor: 29.690

Review 10.  Calcium as a cardiovascular toxin in CKD-MBD.

Authors:  Sharon M Moe
Journal:  Bone       Date:  2016-08-27       Impact factor: 4.398

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.